RecruitingNot ApplicableNCT06576076

Cannabis, Linked Emotions, and Adolescent Risk Study

Characterizing Proximal Risk for Depressive Symptoms and Suicidal Ideation With Acute Cannabis Use and Withdrawal Among Adolescents Using Ecological Momentary Assessment


Sponsor

Massachusetts General Hospital

Enrollment

200 participants

Start Date

Feb 18, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this study is to disentangle relationships between acute cannabis use and withdrawal on proximal depression and suicide risk and recovery in adolescents ages 12-18 years by incorporating time-varying patterns of substance use, mood, and SI. This project aims to guide the development of scalable, individualized, accessible, and affordable interventions aimed to reduce depression and suicide risk among adolescents.


Eligibility

Min Age: 12 YearsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at the link between emotions and cannabis use in teenagers, and whether a smartphone-based support program can help young people who use cannabis frequently and also experience depression or anxiety. **You may be eligible if...** - You are between 12 and 18 years old - You use cannabis 4 or more days per week on average - You have symptoms of depression (score of 5 or higher on a standard questionnaire) - You have access to a smartphone and at least one person who can be contacted in an emergency - A parent or guardian is available to consent (if under 18) **You may NOT be eligible if...** - You are currently in another cannabis treatment study - You have an active diagnosis of psychosis - You are unable to complete phone-based assessments Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALContingency management for cannabis abstinence

Those randomized to the abstinence condition (CB-Abst) will be incentivized using an escalating reinforcement schedule for eight weeks of cannabis abstinence.


Locations(1)

Massachusetts General Hopsital

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06576076


Related Trials